Number: 164 Topic: Generic Drugs - Illegal Activities by Manufacturers <desc> Description: Document will report FDA or Congressional investigations concerning illegal activities by generic drug manufacturers. <narr> Narrative: To be relevant a document must identify a specific generic drug company being investigated by the FDA or Congress. It also must identify the drug, i.e., the generic drug for Zantac. A vague reference to a type of drug, such as pain killer or muscle relaxer is not relevant. A general reference to generic drugs and related problems (quality-control or drug scandals) without specifics is not relevant. Recalls of specific generic drugs that did not live up to FDA standards are relevant. Disputes between drug manufacturers concerning the quality or sales of generic versus name brand drugs including lawsuits are not relevant.